FOURNEL ADVISORY ADVISED ATHENA PHARMACEUTIQUES AND ITS SUBSIDIARY INPHARMASCI IN ARRANGING A BANKING POOL WITH LOCAL PARTNERS TO FINANCE ITS DEVELOPMENT
Athena Pharmaceutiques is a recognized player in the global pharmaceutical industry, thanks to its strong commitment to the development, licensing and manufacture of solid and oral dosage forms.
Athena operates through several strategic entities worldwide, including Athena Pharmaceutiques SAS, Inpharmasci and Substina in France, and Athena DDS in India.
The transaction will enable Athena to finance its own development and that of its subsidiary Inpharmasci, whose plant based near Valenciennes is dedicated to the manufacture of pharmaceutical products for third-party customers (shaping/CMO activity) and for the group itself.